Monashee Investment Management LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Monashee Investment Management LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$832,000
-20.0%
118,027
-33.0%
0.10%
-37.5%
Q1 2021$1,040,000
+10.9%
176,057
+181.7%
0.16%
-62.6%
Q3 2019$938,00062,5000.43%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,431,705$14,371,0005.72%
Ghost Tree Capital, LLC 904,225$5,136,0001.21%
RA Capital Management 5,914,252$34,953,0000.53%
NEA Management Company, LLC 2,997,682$17,716,0000.40%
Vivo Capital, LLC 1,232,394$7,283,0000.26%
Monashee Investment Management LLC 176,057$1,040,0000.16%
Ikarian Capital, LLC 676,294$3,997,0000.14%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$11,146,0000.13%
SAMLYN CAPITAL, LLC 1,232,394$7,283,0000.10%
Maven Securities LTD 173,029$1,026,0000.05%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders